- Home
- ALMU vs GOSS Comparison
ALMU vs GOSS Comparison
Compare ALMU & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMU
- GOSS
- Stock Information
- Founded
- ALMU 2019
- GOSS 2015
- Country
- ALMU United States
- GOSS United States
- Employees
- ALMU 13
- GOSS N/A
- Industry
- ALMU Semiconductors
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- ALMU Technology
- GOSS Health Care
- Exchange
- ALMU Nasdaq
- GOSS Nasdaq
- Market Cap
- ALMU 247.7M
- GOSS 262.5M
- IPO Year
- ALMU N/A
- GOSS 2019
- Fundamental
- Price
- ALMU $15.59
- GOSS $1.38
- Analyst Decision
- ALMU
- GOSS Strong Buy
- Analyst Count
- ALMU 0
- GOSS 3
- Target Price
- ALMU N/A
- GOSS $7.33
- AVG Volume (30 Days)
- ALMU 508.0K
- GOSS 2.5M
- Earning Date
- ALMU 08-07-2025
- GOSS 08-11-2025
- Dividend Yield
- ALMU N/A
- GOSS N/A
- EPS Growth
- ALMU N/A
- GOSS N/A
- EPS
- ALMU N/A
- GOSS N/A
- Revenue
- ALMU $3,627,488.00
- GOSS $124,590,000.00
- Revenue This Year
- ALMU N/A
- GOSS N/A
- Revenue Next Year
- ALMU N/A
- GOSS $91.14
- P/E Ratio
- ALMU N/A
- GOSS N/A
- Revenue Growth
- ALMU 335.67
- GOSS N/A
- 52 Week Low
- ALMU $2.50
- GOSS $0.66
- 52 Week High
- ALMU $19.50
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- ALMU N/A
- GOSS 61.04
- Support Level
- ALMU N/A
- GOSS $1.20
- Resistance Level
- ALMU N/A
- GOSS $1.39
- Average True Range (ATR)
- ALMU 0.00
- GOSS 0.09
- MACD
- ALMU 0.00
- GOSS 0.00
- Stochastic Oscillator
- ALMU 0.00
- GOSS 82.91
About ALMU Aeluma Inc. Common Stock
Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.